Skip to main content
. 2016 Feb 12;5(2):e002756. doi: 10.1161/JAHA.115.002756

Figure 2.

Figure 2

Adjusted event curves for first appropriate therapy. HR indicates hazard ratio. Adjusted for baseline differences in New York Heart Association class, atrial fibrillation, ischemic cardiomyopathy, QRS width, use of cardiac resynchronization therapy with defibrillator, treatment with β‐blockers, amiodarone, spironolactone, calcium channel blockers, antiplatelet agents, and vitamin K antagonists.